Conference abstract · 27 Aug 2018
Conference abstractPublished 2018
Developing bioorthogonal smart polymers for cancer therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The selective delivery and effective localisation of drugs is crucial in cancer therapy. Conventional chemotherapy is subjected to certain drawbacks, such as limitation of tumour-specific receptors that ensure efficient internalisation to enhance drug release as well as significant systemic toxicity to healthy tissues.1 The use of bioorthogonal chemistry is a versatile and promising tool to overcome such drawbacks as it expands the scope of using non-internalising receptors as targets for cancer therapy and selective extracellular release of the drug. Importantly, this drug release stimulus is controlled only by the addition of an exogenous molecule, providing more direct control over in vivo drug release.2 In this work, a 64Cu radiolabelled tetrazine probe (tetrazine-PEG-NOTA) was synthesised, that showed rapid pharmacokinetics in healthy mice when tested in positron emission tomography/computed tomography (PET-CT). Critically, almost all of the tetrazine radioligand was cleared into the bladder within 20 minutes. Additionally, another PET-CT study conducted using a 64Cu radiolabelled PEGNOTA probe showed that tetrazine does not affect the clearance behaviour of the molecule from the bloodstream other than the pathway of clearance. Looking forward, a PEGylated hyperbranched polymer will be synthesised that is conjugated with bispecific antibodies as targeting ligands and trans-cyclooctene moieties bearing the anti-cancer drug doxorubicin. This will be administered to tumour-bearing mice, and following its accumulation at the tumour site, the fast clearing tetrazine probe will be administered. Selective bioorthogonal conjugation of the 64Cu radiolabelled tetrazine probe to trans-cyclooctene through rapid inverse electron demand Diels-Alder cycloaddition will then be monitored in real-time by PET-CT. In this way, the click reaction will facilitate pro-drug activation as well as provide a means to quantify the amount of drug administered at site.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Jun 2025
The Role of Programmed Cell Death in Cancer Development and Therapy
Opinion · 31 May 2025
The Importance of Early-Phase Clinical Trials in Developing New Cancer Therapies
Rapid communication · 31 May 2025
The Promise of Cancer Stem Cell Research in Developing More Effective Cancer Therapies
Article · 19 Dec 2024
The Emerging Role of Artificial Intelligence in Mapping Cancer Mutations and Developing Precision Therapies
More from this journal
The newest in Archives in Cancer Research.
Perspective · 20 Dec 2024
Radiotherapy: Advances, Mechanisms, and Applications in Cancer Treatment
Perspective · 20 Dec 2024
Chemotherapy: A Vital Treatment in the Battle Against Cancer
Perspective · 20 Dec 2024
Tumor Microenvironment: A Key Determinant of Cancer Progression
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives in Cancer Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Gayathri R. Ediriweera”
- BylineArticles whose byline prints “Zachary H Houston”
- BylineArticles whose byline prints “Craig A Bell”
- BylineArticles whose byline prints “Kristofer J Thurecht”

